Portal-splenic-mesenteric venous thrombosis secondary to a mutation of the prothrombin gene;Trombosis venosa portoesplenomesaraica secundaria a mutación del gen de la protrombina

Gastroenterologia y Hepatologia

Volumn 28, Issue 6, 2005, Pages 329-332

  Frutos Bernal, M D ^a   Fernandez Hernandez J A ^a   Carrasco Prats, M ^a   Soria Cogollos, T ^a   Lujan Mompean J A ^a   Hernandez Aguera Q ^a   Parrilla Paricio, P ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; PROTHROMBIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIARRHEA; GENE MUTATION; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MESENTERIC VEIN; MESENTERIC VEIN THROMBOSIS; PORTAL VEIN; PORTAL VEIN THROMBOSIS; SPLENIC VEIN; SUPERIOR MESENTERIC ANGIOGRAPHY; TREATMENT OUTCOME; VEIN THROMBOSIS;

EID: 22544475618     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13076350     Document Type: Article

References (16)

1. Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, et al. Risk factors and clinical presentation of portal vein thombosis in patients with liver cirrhosis. J Hepatol. 2004;40:736-41.
2. Lorenzo-Zuniga F, Morillas RM, Planas R, Ojanguren I, Broggic M, Álvarez MA, et al. Hipertensión portal presinusoidal secundaria a trombosis portal en paciente con síndrome de Allagille. Gastroenterol Hepatol. 2003;26:294-6.
3. Shill M, Henderson JM, Tavill AS. The Budd-Chiari syndrome revisited. Gastroenterologist. 1994;2:27-37.
4. García-Pagán JC. Influencia de los trastornos de la coagulación en las enfermedades vasculares hepáticas y posibilidades terapéuticas. Gastroenterol Hepatol. 2004;27 Supl 1:49-51.
5. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA. 1993;90:1004-8.
6. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′ - untranslated region of the protrombin gene is associated with elevated prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-703.
7. Clavien PA, Durig M, Harder F. Venous mesenteric infarction: a particular entity. Br J Surg. 1988;75:252-5.
8. Madonna P, De Stefano V, Coppola A, Cerbone AM, Di Minno G. G20210A prothrombin gene mutation and other trombophilic polymorphisms in patients with portal or hepatic venous thrombosis. Gastroenterology. 2001;120:1059-67.
9. Al-Juburi A, Scott MA, Shah HR, Raufman JP. Heterozygosity for factor V Leiden and G20210A prothrombin genotypes in a patients with mesenteric vein thrombosis. Dig Dis Sci. 2002;47:601-6.
10. Chamouard P, Pencreach E, Maloisel F, Grunebaum L, Ardizzone JF, Meyer A, et al. Frequent factor II G20210A mutation in idiopathic portal vein thrombosis. Gastroenterology. 1999; 116:144-8.
11. Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Lannaccone L, D'Andrea G, et al. High prevalence of thrombophilic genotypes in patients with acute mesenteric vein thrombosis. Am J Gastroenterol. 2001;96:146-9.
12. De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med. 1999;341: 801-6.
13. Margaglione M, D'Andrea G, Colaizzo G, Del Popolo A, Brancaccio V, Ciampa A, et al. Coexistence of factor V Leiden and factor II G20210 mutations and recurrent venous thromboembolism. Thromb Haemost. 1999;82:1583-7.
14. Condat B, Pressione F, Denneinger MH, Hillaire S, Valla D. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology. 2000;32:466-70.
15. Condat B, Pressione F, Hillaire S, Denninger MH, Guilin MC, Poliguin M, et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology. 2001;120:490-7.
16. Florman SS, Fishbein TM, Schiano T, Letizia A, Fennelly E, DeSancho M. Multivisceral transplantation for portal hypertension and diffuse mesenteric thrombosis caused by protein C deficiency. Transplantation. 2002;74:406-7.